AI Cancer-Fighting Iambic Therapeutics Stock (IAM) Rockets 13% After $150M IPO
Shares in Nvidia ($NVDA)-backed cancer-fighting biotech Iambic Therapeutics ($IAM) soared 13% on its first day of trading following its U.S. IPO. T...
October 15th, 2026 - TipRanks
October 12th, 2026 - Hedge Funds News
September 28th, 2026 - TipRanks
September 27th, 2026 - TipRanks
September 21st, 2026 - TipRanks
September 15th, 2026 - TipRanks
September 10th, 2026 - Hedge Funds News
September 9th, 2026 - TipRanks
September 4th, 2026 - TipRanks
August 20th, 2026 - TipRanks
Returns since its inception in May 2014 (through June 2, 2026)
Subscribe Now30 day money back guarantee. Cancel anytime.
Past performance does not guarantee future returns. Click to see how the portfolio is constructed.